Delivery Order SPE2DE24D0021-SPE2D625F3NCF
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a $1,100 delivery order to Fisher Scientific Company L.L.C. on September 11, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent immunoassay products. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of November 7, 2025, and will be performed at Fisher Scientific's Pittsburgh, Pennsylvania facility. The award utilized no set-aside designation and represents a competitive procurement to...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,105.84 for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment was issued on August 7, 2025, with an ultimate completion date of October 3, 2025. The award was made through open competition with no set-aside designation. The work will be performed in Pittsburgh, Pennsylvania, and is funded by the Defense Department's Medical Supply Chain...
- Fisher Scientific Company L.L.C., a major federal supplier of laboratory and medical equipment, was awarded a delivery order valued at $5,500 on September 12, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent immunodiagnostic supplies. This fixed-price delivery order with economic price adjustment provision will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of November 10, 2025. The contract was awarded without a set-aside designation, indicating open competition. The...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $6,600.00 for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic supplies under a fixed-price contract with economic price adjustment provisions. The contract, awarded on September 12, 2025, with an ultimate completion date of November 10, 2025, will be performed in Pittsburgh, Pennsylvania. The awardee is a major supplier of laboratory supplies, scientific instruments, and medical equipment to federal agencies,...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $5.5K for SOFIA 2 Flu + SARS Antigen Fluorescent I testing supplies under a fixed-price contract with economic price adjustment provisions. The award, issued on September 3, 2025, by the Medical Supply Chain, a defense-focused component within the federal government, is scheduled for completion by October 30, 2025, with performance taking place in Pittsburgh, PA. This delivery order represents a child contract,...
- Fisher Scientific Company L.L.C. was awarded a $3,300 fixed-price delivery order by the Medical Supply Chain division of the Department of Defense on August 20, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. The contract represents an individual delivery order issued under a larger acquisition vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of October 17, 2025. This award was made through open competition with no...
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1.65K to Fisher Scientific Company L.L.C. for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic supplies. This fixed-price delivery order with economic price adjustment capability is scheduled for completion by October 22, 2025, and will be performed at Fisher Scientific's facility in Pittsburgh, Pennsylvania. The award represents a child contract under a larger vehicle structure, with no small...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,658.76 on August 8, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment serves the Medical Supply Chain, a defense-oriented federal agency, with performance to be completed by October 6, 2025, at Fisher Scientific's Pittsburgh, Pennsylvania facility. The contract represents a child award under a larger vehicle and carries no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,650.00 on April 24, 2025, for the procurement of SOFIA 2 FLU + SARS antigen fluorescent testing supplies. This fixed-price contract with economic price adjustment is being performed in Pittsburgh, Pennsylvania, and is funded by the Defense-affiliated Medical Supply Chain agency. As a child contract under a larger vehicle, this delivery order represents a discrete procurement from Fisher Scientific's existing blanket...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $2,764.60 by the Defense Medical Supply Chain for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic testing supplies. The delivery order, issued on August 8, 2025, is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of October 6, 2025. The work will be performed in Pittsburgh, Pennsylvania. This award represents a child...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3NCFDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,200 for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent testing supplies. The award, issued on September 15, 2025, is a fixed-price contract with economic price adjustment provisions, with an ultimate completion date of November 12, 2025. The contract will be performed in Pittsburgh, Pennsylvania, and was funded through the Department of Defense's Medical Supply Chain division. No set-aside designation was used in this award, reflecting Fisher Scientific's competitive capabilities in federal procurement. This delivery order is a child contract, indicating it falls under a larger contract vehicle or blanket purchase agreement. Fisher Scientific, a major supplier of laboratory and medical equipment to federal agencies since 2001, has demonstrated extensive experience fulfilling similar procurement requirements across the Department of Defense, National Institutes of Health, and Department of Veterans Affairs. The SOFIA 2 testing supplies support diagnostic capabilities for influenza and SARS-related pathogens, aligning with the Department of Defense's medical readiness and healthcare mission requirements. The relatively modest contract value reflects this as a targeted procurement for specific diagnostic reagents rather than a large-scale equipment acquisition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/15/25 |